PXL/HO/Cir-041/2026-27                                                                                          Date: 20.07.2026

Hyderabad

Subject:Bulk Subscription Offer – Indian Pharmacopoeia (IP-2026) Online Access

Dear Member,

Greetings from Pharmexcil!

We are glad to inform that the Indian Pharmacopoeia Commission (IPC) has extended a special subscription offer to the members of Pharmexcil for the online version of 10th Edition of Indian Pharmacopoeia (IP-2026), along with access to IP-2022 and Addendum 2024. This initiative is designed to ensure that all member organizations benefit from the latest official standards, thereby strengthening regulatory compliance, quality assurance, and harmonized pharmaceutical practices across the sector.

Subscription Model Highlights:

• Offer Price:Rs. 45,000/- + 5% GST per subscriber (original price is Rs.60,000+ 5% GST per user)
• Access Includes:IP-2026, IP-2022, and Addendum 2024 (online version)
• Minimum Subscribers:100 (bulk procurement basis)
• Payment Terms:Full advance payment by Pharmexcil to IPC in lumpsum
• MSME Participation:Encouraged under this bulk purchase scheme
• Validity: Till the release of next edition
• Limited Period Offer

Action Required:Members are requested to confirm their interest by filling out the Google Form linked below:

Google Form – IP-2026 Subscription Interest

Pharmexcil will consolidate subscriber details and share them with IPC to proceed with the bulk procurement.

We look forward to your active participation in strengthening the adoption of the Indian Pharmacopoeia across the pharmaceutical ecosystem.

With regards,

Raja Bhanu
Director General